Subscribe to RSS
DOI: 10.1055/s-0034-1391285
Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial
Publication History
submitted 17 February 2014
accepted after revision 11 November 2014
Publication Date:
10 February 2015 (online)
Background and study aims: Endoscopic radiofrequency ablation (RFA) is an established therapy for Barrett’s esophagus. Preliminary reports, limited by low patient numbers, also suggest a possible role for RFA in early esophageal squamous cell neoplasia (ESCN). The aim of this study was to evaluate the safety and effectiveness of RFA for early ESCN (moderate/high grade intraepithelial neoplasia [MGIN/HGIN] and early flat-type esophageal squamous cell carcinoma [ESCC]).
Patients and methods: This prospective cohort study included patients with at least one flat (type 0-IIb) unstained lesion (USL) on Lugol’s chromoendoscopy and a consensus diagnosis of MGIN, HGIN, or early ESCC. RFA was used at baseline to treat all USLs, and then biopsy (and focal RFA if USL persisted) was performed every 3 months until all biopsies were negative for MGIN, HGIN, and ESCC. The main outcome measurements were complete response at 3 and 12 months (absence of MGIN, HGIN, and ESCC), neoplastic progression, and adverse events.
Results: A total of 96 patients participated (MGIN 45, HGIN 42, early ESCC 9). At 3 and 12 months, 73 % (70/96) and 84 % (81/96), respectively, showed a complete response. Two patients (2 %) progressed (MGIN to HGIN; HGIN to T1m2 ESCC); both were treated endoscopically and achieved complete response. Stricture occurred in 20 patients (21 %), all after circumferential RFA. Lugol’s + RFA 12 J/cm2 (single application, no cleaning) was the favored baseline circumferential RFA technique (82 % 12-month complete response [14/17], 6 % stricture [6/17]).
Conclusion: In patients with early ESCN, RFA was associated with a high complete response rate and an acceptable safety profile.
* These authors contributed equally to this work.
-
References
- 1 Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917
- 2 Kamangar F, Chow WH, Abnet CC et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009; 38: 27-57, vii
- 3 Lin Y, Totsuka Y, He Y et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol 2013; 23: 233-242
- 4 Wu C, Kraft P, Zhai K et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nature Genetics 2012; 44: 1090-1097
- 5 Dawsey SM, Lewin KJ, Liu FS et al. Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer 1994; 73: 2027-2037
- 6 Dawsey SM, Lewin KJ, Wang GQ et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994; 74: 1686-1692
- 7 Wang GQ, Abnet CC, Shen Q et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005; 54: 187-192
- 8 Jin XF, Sun Qy, Chai TH et al. Clinical value of multiband mucosectomy for the treatment of squamous intraepithelial neoplasia of the esophagus. J Gastroenterol Hepatol 2013; 28: 650-655
- 9 Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 1245-1255
- 10 Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
- 11 Bergman JJ, Zhang YM, He S et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc 2011; 74: 1181-1190
- 12 van Vilsteren FG, Alvarez Herrero L, Pouw RE et al. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma. Endoscopy 2011; 43: 282-290
- 13 Becker V, Bajbouj M, Schmid RM et al. Multimodal endoscopic therapy for multifocal intraepithelial neoplasia and superficial esophageal squamous cell carcinoma – a case series. Endoscopy 2011; 43: 360-364
- 14 Ciocirlan M, Lapalus MG, Hervieu V et al. Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 2007; 39: 24-29
- 15 Pech O, May A, Gossner L et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 2007; 39: 30-35
- 16 Ishihara R, Iishi H, Uedo N et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008; 68: 1066-1072
- 17 Fujishiro M, Yahagi N, Kakushima N et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 2006; 4: 688-694
- 18 Repici A, Hassan C, Carlino A et al. Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 2010; 71: 715-721
- 19 Wen J, Linghu E, Yang Y et al. Relevant risk factors and prognostic impact of positive resection margins after endoscopic submucosal dissection of superficial esophageal squamous cell neoplasia. Surg Endosc 2014; 28: 1653-1659
- 20 Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol 2013; 19: 1424-1437
- 21 Seewald S, Ang TL, Omar S et al. Endoscopic mucosal resection of early esophageal squamous cell cancer using the Duette mucosectomy kit. Endoscopy 2006; 38: 1029-1031
- 22 Oyama T. Endoscopic treatment for esophageal squamous cell carcinoma. Recent Results Cancer Res 2012; 196: 143-154
- 23 Teoh AY, Chiu PW, Ngo DK et al. Outcomes of endoscopic submucosal dissection versus endoscopic mucosal resection in management of superficial squamous esophageal neoplasms outside Japan. J Clin Gastroenterol 2010; 44: e190-194
- 24 Ishii N, Horiki N, Itoh T et al. Endoscopic submucosal dissection with a combination of small-caliber-tip transparent hood and flex knife is a safe and effective treatment for superficial esophageal neoplasias. Surg Endosc 2010; 24: 335-342
- 25 Hashimoto S, Kobayashi M, Takeuchi M et al. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 2011; 74: 1389-1393
- 26 Luketich JD, Pennathur A, Awais O et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 2012; 256: 95-103
- 27 Markar SR, Karthikesalingam A, Thrumurthy S et al. Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000 – 2011. J Gastrointest Surg 2012; 16: 1055-1063
- 28 Yamamoto M, Weber JM, Karl RC et al. Minimally invasive surgery for esophageal cancer: review of the literature and institutional experience. Cancer Control 2013; 20: 130-137
- 29 Perry KA, Funk LM, Muscarella P et al. Perioperative outcomes of laparoscopic transhiatal esophagectomy with antegrade esophageal inversion for high-grade dysplasia and invasive esophageal cancer. Surgery 2013; 154: 901-907
- 30 Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis Esophagus 1997; 10: 155-158
- 31 Noguchi H, Naomoto Y, Kondo H et al. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma. Surg Laparosc Endosc Percutan Tech 2000; 10: 343-350
- 32 Akutsu Y, Uesato M, Shuto K et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg 2013; 257: 1032-1038
- 33 Shimizu M, Ban S, Odze RD. Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma. Gastroenterol Clin North Am 2007; 36: 797-811
- 34 Kume K. The local recurrence and the metachronous cancer after EMR for early esophageal cancer confined within the lamina propria mucosae. Hepatogastroenterology 2009; 56: 699-702
- 35 Nakagawa K, Koike T, Iijima K et al. Comparison of the long-term outcomes of endoscopic resection for superficial squamous cell carcinoma and adenocarcinoma of the esophagus in Japan. Am J Gastroenterol 2014; 109: 348-356
- 36 Dawsey SM, Fleischer DE, Wang GQ et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998; 83: 220-231
- 37 Fornari F, Wagner R. Update on endoscopic diagnosis, management and surveillance strategies of esophageal diseases. World J Gastrointest Endosc 2012; 4: 117-122
- 38 Takahashi H, Arimura Y, Masao H et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010; 72: 255-264
- 39 Ono S, Fujishiro M, Goto O et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 2009; 70: 860-866